Nucleus accumbens-associated 1 contributes to cortactin deacetylation and augments the migration of melanoma cells

Journal of Investigative Dermatology

Volumn 131, Issue 8, 2011, Pages 1710-1719

  Tsunoda, Kanako ^a,b   Oikawa, Hiroki ^b   Tada, Hiroshi ^a   Tatemichi, Yoshinori ^a   Muraoka, Sosuke ^a,b   Miura, Shinpei ^a,b   Shibazaki, Masahiko ^a   Maeda, Fumihiko ^b   Takahashi, Kazuhiro ^b   Akasaka, Toshihide ^b   Masuda, Tomoyuki ^b   Maesawa, Chihaya ^a  

^a Division of Bioscience   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CELL MEMBRANE PROTEIN; CORTACTIN; HISTONE DEACETYLASE 6; NUCLEUS ACCUMBENS ASSOCIATED 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL MIGRATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEACETYLATION; DISTANT METASTASIS; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 79960322413     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.110     Document Type: Article

References (46)

1. Abhiman S, Iyer LM, Aravind L (2008) BEN: a novel domain in chromatin factors and DNA viral proteins. Bioinformatics 24:458-61 (Pubitemid 351256287)
2. Bowden ET, Barth M, Thomas D et al. (1999) An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18:4440-9 (Pubitemid 29396652)
3. Bringuier PP, Tamimi Y, Schuuring E et al. (1996) Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 12:1747-53 (Pubitemid 26146299)
4. Bryce NS, Clark ES, Leysath JL et al. (2005) Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol15:1276-85 (Pubitemid 41026593)
5. Buday L, Downward J (2007) Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta 1775:263-73 (Pubitemid 46899339)
6. Gajewski TF (2007) Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin Cancer Res 13:5256-61 (Pubitemid 47510348)
7. Gibcus JH, Mastik MF, Menkema L et al. (2008) Cortactin expression predicts poor survival in laryngeal carcinoma. Br JCancer98:950-5 (Pubitemid 351341606)
8. Head JA, Jiang D, Li M et al. (2003) Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoske-leton. Mol Biol Cell14:3216-29 (Pubitemid 37013122)
9. Howe AK, Hogan BP, Juliano RL (2002) Regulation ofvasodilator-stimulated phosphoprotein phosphorylation and interaction with Abl by protein kinase A and cell adhesion. J Biol Chem 277:38121-6 (Pubitemid 35154664)
10. Ishibashi M, Nakayama K, Yeasmin S et al. (2008) A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer. Clin Cancer Res 14:3149-55
11. Jinawath N, Vasoontara C, Yap KL et al. (2009) NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway. Oncogene28:1941-8
12. Kaksonen M, Peng HB, Rauvala H (2000) Association of cortactin with dynamic actin in lamellipodia and on endosomal vesicles. J Cell Sci 113(Pt 24):4421-6 (Pubitemid 32117902)
13. Kim J, Chu J, Shen X et al. (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell132:1049-61 (Pubitemid 351381745)
14. Kim YB, Lee SY, Ye SK et al. (2007) Epigenetic regulation of integrin-linked kinase expression depending on adhesion of gastric carcinoma cells. Am J Physiol Cell Physiol 292:C857-66
15. Korutla L, Wang PJ, Mackler SA (2005) The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures. J Neurochem 94:786-93 (Pubitemid 41098510)
16. Kowalski JR, Egile C, Gil S et al. (2005) Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 118:79-87 (Pubitemid 40277106)
17. Kruchten AE, Krueger EW, Wang Y et al. (2008) Distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhe-sions. Am J Physiol Cell Physiol 295:C1113-22 (Pubitemid 352790348)
18. Lambrechts A, Kwiatkowski AV, Lanier LM et al. (2000) c AMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J Biol Chem 275:36143-51
19. Li Y, Tondravi M, Liu J et al. (2001) Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61:6906-11 (Pubitemid 32896517)
20. Luo ML, Shen XM, Zhang Y et al. (2006) Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66:11690-9 (Pubitemid 46094181)
21. Marks R (2000) Epidemiology of melanoma. Clin Exp Dermatol 25:459-63
22. Nakayama K, Nakayama N, Davidson B et al. (2006) A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci USA 103:18739-44 (Pubitemid 44913480)
23. Nakayama K, Nakayama N, Wang TL et al. (2007) NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor. Cancer Res 67:8058-64 (Pubitemid 47395140)
24. Patel AM, Incognito LS, Schechter GL et al. (1996) Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 12:31-5 (Pubitemid 26041237)
25. Patel AS, Schechter GL, Wasilenko WJ et al. (1998) Overexpression of EMS1/ cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16:3227-32 (Pubitemid 28330420)
26. Postovit LM, Seftor EA, Seftor RE et al. (2006) Influence of the microenviron-ment on melanoma cell fate determination and phenotype. Cancer Res 66:7833-6 (Pubitemid 44299141)
27. Rodrigo JP, Garcia LA, Ramos S et al. (2000) EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6:3177-82 (Pubitemid 30637745)
28. Rothschild BL, Shim AH, Ammer AG et al. (2006) Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 66:8017-25 (Pubitemid 44299166)
29. Satyamoorthy K, Herlyn M (2002) Cellular and molecular biology of human melanoma. Cancer Biol Ther 1:14-7
30. Schuuring E, Verhoeven E, Litvinov S et al. (1993) The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol 13:2891-8 (Pubitemid 23133960)
31. Shen H, Korutla L, Champtiaux N et al. (2007) NAC1 regulates the recruitment of the proteasome complex into dendritic spines. J Neurosci 27:8903-13 (Pubitemid 47292755)
32. Soengas MS, Lowe SW (2003) Apoptosis and melanoma chemoresistance. Oncogene 22:3138-51 (Pubitemid 36713766)
33. Uruno T, Liu J, Zhang P et al. (2001) Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol 3:259-66 (Pubitemid 32201321)
34. van Rossum AG, Gibcus J, van der Wal J et al. (2005) Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells. Breast Cancer Res 7:235-7 (Pubitemid 41830158)
35. Wang GC, Hsieh PS, Hsu HH et al. (2009) Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness. World J Urol 27:557-63
36. Wang X, Cao W, Mo M et al. (2010) VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. J Surg Oncol 102:325-30
37. Weaver AM, Karginov AV, Kinley AW et al. (2001) Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 11:370-4 (Pubitemid 32200742)
38. Weed SA, Du Y, Parsons JT (1998) Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1. J Cell Sci 111 (Pt 16):2433-43 (Pubitemid 28434929)
39. Wu H, Parsons JT (1993) Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120:1417-26 (Pubitemid 23081688)
40. Xu XZ, Garcia MV, Li TY et al. (2010) Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol 23:187-96
41. Yamada S, Yanamoto S, Kawasaki G et al. (2010) Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma. Pathol Oncol Res 16:523-31
42. Yang XJ, Gregoire S (2005) Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 25: 2873-84 (Pubitemid 40464294)
43. Yeasmin S, Nakayama K, Ishibashi M et al. (2008) Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis. Clin Cancer Res 14:1686-91 (Pubitemid 351469452)
44. Yuan BZ, Zhou X, Zimonjic DB et al. (2003) Amplification and over-expression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J Mol Diagn 5:48-53 (Pubitemid 36193000)
45. Zhang X, Yuan Z, Zhang Y et al. (2007) HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell27:197-213 (Pubitemid 47058299)
46. Zhang Y, Zhang M, Dong H et al. (2009) Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28:445-60